CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net earnings including non-controlling interests	$ 292	$ 719
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	287	280
Asset impairment charges	0	3
Deferred income taxes	(42)	(64)
Equity in earnings of affiliates, net of dividends	(28)	(136)
Stock compensation expense	50	66
(Gain) Loss on sales / investment revaluation	(26)	14
Other – net	(94)	0
Changes in operating assets and liabilities
Segregated investments	220	(159)
Trade receivables	(655)	61
Inventories	137	295
Other current assets	263	163
Trade payables	(423)	(713)
Payables to brokerage customers	(79)	319
Accrued expenses and other payables	(244)	(148)
Net cash (used in) provided by operating activities	(342)	700
Cash flows from investing activities
Capital expenditures	(291)	(328)
Net assets of businesses acquired	(90)	(915)
Proceeds from sales of assets	10	6
Purchases of marketable securities	(11)	0
Proceeds from sales of marketable securities	248	0
Other – net	5	7
Net cash used in investing activities	(129)	(1,230)
Cash flows from financing activities
Net borrowings under lines of credit agreements	863	1,619
Share repurchases, net of tax	0	(1,327)
Cash dividends	(247)	(257)
Other – net	(29)	(37)
Net cash provided by (used in) financing activities	587	(2)
Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents	16	(13)
Increase (Decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents	132	(545)
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period	3,924	5,390
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period	$ 4,056	$ 4,845